Avermectin derivatives, pharmacokinetics, therapeutic and toxic dosages, mechanism of action, and their biological effects
G El-Saber Batiha, A Alqahtani, OB Ilesanmi, AA Saati… - Pharmaceuticals, 2020 - mdpi.com
Avermectins are a group of drugs that occurs naturally as a product of fermenting
Streptomyces avermitilis, an actinomycetes, isolated from the soil. Eight different structures …
Streptomyces avermitilis, an actinomycetes, isolated from the soil. Eight different structures …
Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes
H Kaur, N Shekhar, S Sharma, P Sarma… - Pharmacological …, 2021 - Springer
Introduction COVID-19 cases are on surge; however, there is no efficient treatment or
vaccine that can be used for its management. Numerous clinical trials are being reviewed for …
vaccine that can be used for its management. Numerous clinical trials are being reviewed for …
Vaccine hesitancy: Beliefs and barriers associated with COVID‐19 vaccination among Egyptian medical students
SM Saied, EM Saied, IA Kabbash… - Journal of medical …, 2021 - Wiley Online Library
Background Vaccine hesitancy poses serious challenges for achieving coverage for
population immunity. It is necessary to achieve high COVID‐19 vaccination acceptance …
population immunity. It is necessary to achieve high COVID‐19 vaccination acceptance …
Clinical study evaluating the efficacy of ivermectin in COVID‐19 treatment: A randomized controlled study
S Abd‐Elsalam, RA Noor, R Badawi… - Journal of medical …, 2021 - Wiley Online Library
Researchers around the world are working at record speed to find the best ways to treat and
prevent coronavirus disease 2019 (COVID‐19). This study aimed to evaluate the efficacy of …
prevent coronavirus disease 2019 (COVID‐19). This study aimed to evaluate the efficacy of …
[HTML][HTML] Efficacy and safety of ivermectin for treatment and prophylaxis of COVID-19 pandemic
A Elgazzar, A Eltaweel, SA Youssef, B Hany, M Hafez… - 2020 - europepmc.org
Background: Up-to-date, there is no recognized effective treatment or vaccine for the
treatment of COVID-19 that emphasize urgency around distinctive effective therapies. This …
treatment of COVID-19 that emphasize urgency around distinctive effective therapies. This …
[HTML][HTML] Combined therapy with ivermectin and doxycycline can effectively alleviate the cytokine storm of COVID-19 infection amid vaccination drive: A narrative …
An unprecedented global health crisis has developed due to the emergence of the
mysterious coronavirus-2 of the severe acute respiratory syndrome, which has resulted in …
mysterious coronavirus-2 of the severe acute respiratory syndrome, which has resulted in …
Corona viruses: a review on SARS, MERS and COVID-19
NN Chathappady House, S Palissery… - Microbiology …, 2021 - journals.sagepub.com
After the outbreak of SARS and MERS, the world is now in the grip of another viral disease
named COVID-19 caused by a beta Coronavirus–SARS COV-2 which appears to be the …
named COVID-19 caused by a beta Coronavirus–SARS COV-2 which appears to be the …
Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: a randomized multi-center clinical trial
MS Niaee, P Namdar, A Allami, L Zolghadr… - Asian Pacific Journal …, 2021 - journals.lww.com
Objective: To evaluate different doses of ivermectin in adult patients with mild COVID-19 and
to evaluate the effect of ivermectin on mortality and clinical consequences. Methods: A …
to evaluate the effect of ivermectin on mortality and clinical consequences. Methods: A …
Phase 2 randomized study on chloroquine, hydroxychloroquine or ivermectin in hospitalized patients with severe manifestations of SARS-CoV-2 infection
LEB Galan, NM Santos, MS Asato… - Pathogens and global …, 2021 - Taylor & Francis
Objective: Given the urgent need for strategies to minimize the damage caused by this
pandemic, this study performed a randomized, double-blind phase 2 study to assess the …
pandemic, this study performed a randomized, double-blind phase 2 study to assess the …
[HTML][HTML] A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19
The emergence of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected many countries throughout …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected many countries throughout …